A series of novel [1, 2, 4] triazolo [4,3-a]quinoxalinone derivatives have been synthesized. The structures of the newly synthesized compounds were confirmed by elemental analysis and different spectral techniques. The in vitro antimicrobial screening of some selected compounds was carried out using the diffusion agar technique. Compound 14 c was found to be the most active antibacterial agent against Escherichia coli using gentamicin as reference drug. All the tested compounds showed no activity against Candida albicans and Pseudomonas aerugeosa.
Introduction
Although antibacterial agents are life saving drugs, yet they suffer from serious drawbacks. The most important of which is anaphylaxis and developing resistance which implement a potential global health crisis. It is recommended to use new antibacterial agents with enhanced broad-spectrum potency. Therefore, recent efforts have been directed toward exploring novel antibacterial agents. Quinoxaline derivatives are important components of several pharmacologically active compounds [Tandon et al., 2006; Sarges et al., 1990; Sakata et al., 1988; Arthur et al., 2005; Seitz et al., 2002; Szekelyhidi et al., 2005] . Although rarely described in nature, synthetic quinoxaline ring is part of number of antibiotics such as echinomycin and actinomycin, which are known to inhibit the growth of Gram-positive bacteria and are also active against various transplantable tumors [ Myers et al., 2003; Iwashita et al., 2005; Morokata et al., 2004] . Substituted quinoxaline have received considerable attention during last decade as they are endowed with variety of biological activities and have wide range of therapeutic properties such as antibacterial, antiviral, anticancer, antifungal, anthelmintic, and insecticidal [ Badran et al., 2003; Catarzi et al., 2004; Gali-Muhtasib et al., 2005; Perez-Melero et al., 2004; Kim et al., 2004; Toshima et al., 2004] . Relying on this evidence we became motivated to synthesize some novel [1, 2, 4] triazolo [4,3-a] quinoxalinone derivatives in an attempt to find an effective antimicrobial agent.
Results and Discussion
The present work involves preparation of some novel [1, 2, 4] triazolo [4,3-a] quinoxalinone derivatives. Achieving this goal was made by adopting the synthetic pathway depicted in schemes I and II. The main intermediate in this work is 3-hydrazinylquinoxalinone 2 which has been synthesized in two steps starting from Ophenylenediamine by treating it with oxalic acid to produce quinoxalinedione 1. Reacting 1 with hydrazine hydrate afforded the hydrazinylquinoxalinone 2. Triazoloquionxalinone derivatives 3, 4 and 5 have been prepared from compound 2 using established procedures Scheme I. Potassium salts 6, 7 and 8 were obtained after treatment of compounds 3, 4 and 5 with alcoholic KOH in quantitative yields. Reaction of potassium salts 6, 7 and 8 with ethylchloroacetate gave the corresponding esters 9, 10 and 11 respectively. Reaction of potassium salts 6, 7 and 8 with chloroacetanilides produced the corresponding anilides 12a-h, 13a-i and 14a-h Scheme II. The IR spectra of these compounds are characterized by appearance of amid carbonyl at 1681-1681cm -1 and amidic -NH at 3245-3448 cm -1 .
The structural assignments to the new compounds were based on their elemental analysis and spectral (IR, 1 HNMR and mass) data.
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All melting points were taken on Stuart SMP3 digital melting point apparatus and Gallen Kamp apparatus and were uncorrected.IR spectra were recorded on Pye Unicam SP 1000 IR spectrophotometer at Microanalytical Center, Cairo University. 
According to certain reported procedures, the following derivatives were prepared:
Quinoxaline-2,3(1H,4H)-dione ( Romer, 2009 ), 3-hydrazinylquinoxalin-2(1H)-one ( Newbold et al., 1948) , [1, 2, 4] triazolo [4,3-a] quinoxalin-4(5H)-one ( Galal et al., 2013) , 1-methyl- [1, 2, 4] triazolo [4,3-a] quinoxalin-4(5H)-one ( Rashed et al., 1990 ) and 1-(trifluoromethyl)- [1, 2, 4] triazolo [4,3-a] quinoxalin-4(5H)-one (Bharat et al., 1988) , Chloroacetailides (El-Said et al., 1991) .
Potassium salt of [1,2,4]triazolo[4,3-a]quinoxalin-4(5H)-one (6), Potassium salt of 1-methyl-[1,2,4]triazolo[4,3-a]quinoxalin-4(5H)-one (7) and Potassium salt of 1-(trifluoromethyl)-[1,2,4]triazolo[4,3-a]quinoxalin-4(5H)-one (8):
To a solution of the appropriate (1,2,4)-triazolo [4,3-a] quinazolinone of type 3, 4 and 5 (0.01mol each) in absolute ethanol, solution KOH (0.01mol) in absolute ethanol was added and the reaction mixture was heated to 78⁰C with stirring for 15minutes. The produced solid was collected by filtration, washed several times with absolute ethanol and dried producing the target compounds in quantitative yield. 
General procedure
In a conical flask equimolar quantities (0.01mol each) of the suitable salt 6 or 7 or 8 and ethyl chloroacetate were suspended in (20ml) DMF and heated on water bath for 3h. The reaction mixture was poured onto ice water (200 ml), and stirred for 30min.
The obtained solid was filtered and crystallized from acetone: methanol (1:5) mixture. 
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Antimicrobial activity
Preliminary antibacterial and antifungal activity were performed for selected compounds against various types of bacteria and fungi, namely: Materials Culture media Nutrient broth, Sabourauds broth and Nutrient agar were the products of Oxoid ltd., England. Methodology: the agar plate disc-diffusion technique (Collins, 1964) Sterilized filter paper discs (6 mm in diameter) were wetted each with 100μl of a solution of the tested compound containing 2mg/ml in DMF and the discs were allowed to air dry. The discs were then placed onto the surface of agar plates (nutrient agar for bacteria and sabourauds dextrose agar for fungi) seeded with the test organism. Each plate contained 15 ml of the agar medium, previously seeded with 0.2 ml of 18 hours broth culture of each organism. The inoculated plates were incubated at 37 ⁰C for 48 hours and the mean zone of inhibition ± standard deviation beyond well diameter were measured in mm. Discs impregnated with DMF were used as control. The antibacterial reference Ampiciliin and Gentamicin and the antifungal reference Amphotericin B discs were tested concurrently as a standard. 
Results of antimicrobial activity
From table 4, it was found that in vitro antimicrobial testing revealed that compounds 12 a , 12 c , 13 a and 14a were found to be more active than the reference drugs amphotericin B and gentamicin on Syncephalastrum racemosum and Escherichia coli. compound 14c showed the most activity against Escherichia coli. Compound 14 g which bearing trifluoromethyl group in position 1 and an electron donating (methoxy) group in position 3 of phenyl ring in the phenylacetamide residue has broad spectrum antimicrobial activity against the tested organisms. All the tested compounds showed no activity against Candida albicans and Pseudomonas aerugenosa. The presence of trifluoromethyl group in position 1 has profound effect on biological activity as noticed in compound 14 a , 14 b and 14 g .
